STAGE IV PROSTATE CANCER
Clinical trials for STAGE IV PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE IV PROSTATE CANCER trials appear
Sign up with your email to follow new studies for STAGE IV PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New adaptive therapy aims to outsmart prostate cancer
Disease control OngoingThis early-phase trial tests an adaptive approach to hormone therapy for men with stage IV prostate cancer that still responds to hormone treatment. Instead of a fixed schedule, the treatment is adjusted based on PSA levels. The study includes 17 participants and combines standar…
Matched conditions: STAGE IV PROSTATE CANCER
Phase: EARLY_PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 23, 2026 12:09 UTC
-
New hope for tough prostate cancer: targeted drug combo shows promise
Disease control OngoingThis study tests three treatment options for men with advanced prostate cancer that no longer responds to hormone therapy and has specific DNA repair defects. Participants receive either abiraterone (a hormone blocker), olaparib (a targeted drug), or both together. The goal is to…
Matched conditions: STAGE IV PROSTATE CANCER
Phase: PHASE2 • Sponsor: Northwestern University • Aim: Disease control
Last updated Jun 18, 2026 11:51 UTC
-
New hope for tough prostate cancer: drug combo targets bone tumors
Disease control OngoingThis study looks at men with advanced prostate cancer that no longer responds to hormone therapy and has spread to bones. It compares the drug enzalutamide alone versus enzalutamide plus a radioactive treatment (radium-223) to see how they affect the immune system and bone tumors…
Matched conditions: STAGE IV PROSTATE CANCER
Phase: PHASE2 • Sponsor: University of Southern California • Aim: Disease control
Last updated Jun 18, 2026 11:50 UTC
-
Triple therapy shows promise for aggressive prostate cancer
Disease control OngoingThis early-phase study tested a combination of enzalutamide (a hormone-blocking drug), radiation therapy, and standard hormone therapy in 25 men with intermediate or high-risk prostate cancer. The main goal was to check for side effects and find the best way to give the treatment…
Matched conditions: STAGE IV PROSTATE CANCER
Phase: PHASE1 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Jun 11, 2026 12:10 UTC
-
Evolutionary strategy takes on tough prostate cancer
Disease control OngoingThis study tests a two-step treatment plan for men with high-risk metastatic prostate cancer. First, patients receive hormone therapy plus a newer drug, followed by chemotherapy. The goal is to improve survival by attacking the cancer in a sequence inspired by how species go exti…
Matched conditions: STAGE IV PROSTATE CANCER
Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 08, 2026 13:06 UTC
-
Prostate cancer drugs may cloud your mind: new study investigates
Knowledge-focused OngoingThis study looks at how certain hormone therapies for advanced prostate cancer might affect memory, thinking, and brain structure. Researchers will use brain scans and thinking tests in 100 men to track changes over time. The goal is to understand which patients are more likely t…
Matched conditions: STAGE IV PROSTATE CANCER
Phase: PHASE4 • Sponsor: Northwestern University • Aim: Knowledge-focused
Last updated Jun 03, 2026 12:07 UTC